22 results
S-1/A
EX-10.1
STOK
Stoke Therapeutics Inc
7 Jun 19
IPO registration (amended)
6:08am
or Indemnitee in the five years preceding the time in question and that would not, under applicable standards of professional conduct, have a conflict … of interest in representing either the Company or Indemnitee.
(g) Independent Director. For purposes of this Agreement, “Independent Director” means
DRS
EX-4.2
STOK
Stoke Therapeutics Inc
26 Mar 19
Draft registration statement
12:00am
-client privilege between the Company and its counsel or result in disclosure of trade secrets or a direct conflict of interest, or if such Investor or its … or result in disclosure of trade secrets or a conflict of interest, or if such Investor or its representative is a Competitor of the Company
S-1
EX-4.2
STOK
Stoke Therapeutics Inc
23 May 19
IPO registration
4:02pm
or result in disclosure of trade secrets or a direct conflict of interest, or if such Investor or its representative is a Competitor of the Company. RTW … between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if such Investor or its representative
S-1
EX-10.10
STOK
Stoke Therapeutics Inc
23 May 19
IPO registration
4:02pm
are not a conflict of interest or interfere in any material way with your duties under this Agreement.
2.Election to Board. You have been elected
PRE 14A
wxcfjm8q30k0e3
17 Apr 23
Preliminary proxy
4:01pm
S-1
EX-3.4
det2s1shzsclvs
23 May 19
IPO registration
4:02pm
S-3
EX-3.2
q5ype26ba1
10 Jul 20
Shelf registration
4:06pm
S-3
EX-4.4
ikogkvg 4v9
10 Jul 20
Shelf registration
4:06pm
DRS/A
hfjybf0
30 Apr 19
Draft registration statement (amended)
12:00am
DRS
ou2n8ixgmy
26 Mar 19
Draft registration statement
12:00am
424B4
cvroos1r7mwm4y5rmqp
19 Jun 19
Prospectus supplement with pricing info
4:16pm